0001415889-24-002393.txt : 20240202
0001415889-24-002393.hdr.sgml : 20240202
20240202183006
ACCESSION NUMBER: 0001415889-24-002393
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240201
FILED AS OF DATE: 20240202
DATE AS OF CHANGE: 20240202
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Alrutz Michael Albert
CENTRAL INDEX KEY: 0001422345
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35867
FILM NUMBER: 24593308
MAIL ADDRESS:
STREET 1: 2530 MERIDIAN PARKWAY
STREET 2: 2ND FLOOR
CITY: DURHAM
STATE: NC
ZIP: 27713
FORMER NAME:
FORMER CONFORMED NAME: Alrutz Michael A
DATE OF NAME CHANGE: 20080102
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CHIMERIX INC
CENTRAL INDEX KEY: 0001117480
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 330903395
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2505 MERIDIAN PARKWAY, SUITE 100
CITY: DURHAM
STATE: NC
ZIP: 27713
BUSINESS PHONE: 919.806.1074
MAIL ADDRESS:
STREET 1: 2505 MERIDIAN PARKWAY, SUITE 100
CITY: DURHAM
STATE: NC
ZIP: 27713
4
1
form4-02022024_110241.xml
X0508
4
2024-02-01
0001117480
CHIMERIX INC
CMRX
0001422345
Alrutz Michael Albert
C/O CHIMERIX, INC.
2505 MERIDIAN PARKWAY, SUITE 100
DURHAM
NC
27713
false
true
false
false
SVP AND GENERAL COUNSEL
0
Common Stock
2024-02-01
4
A
0
21875
0
A
168098
D
Stock Option (Right to Buy)
.93
2024-02-01
4
A
0
131250
0
A
2034-01-31
Common Stock
131250
131250
D
The shares being reported are being issued pursuant to restricted unit awards ("RSUs"), each one of which represents a contingent right to receive one share of the Issuer's common stock. 5,468 shares subject to the RSUs will vest on the one-year anniversary of the date of grant, 5,468 shares subject to the RSUs will vest on the second-year anniversary of the date of grant, 5,468 shares subject to the RSUs will vest on the third-year anniversary of the date of grant, and 5,471 shares subject to the RSUs will vest on the fourth-year anniversary of the date of grant.
Includes 1,809 shares acquired under the Issuer's Employee Stock Purchase Plan (the "ESPP") on March 10, 2023 and 2,399 shares acquired under the ESPP on September 8, 2023.
1/48th of the shares subject to the option vest in equal monthly installments over a four year period following the date of grant.
/s/ Michael Alrutz, Attorney-in-Fact
2024-02-02